Birelentinib, CAS [[2662512-15-2]] Preis auf Anfrage
Biozol Catalog Number:
MCE-HY-160167
Supplier Catalog Number:
HY-160167
Alternative Catalog Number:
MCE-HY-160167-1UNIT
Manufacturer:
MedchemExpress
Category:
Biochemikalien
Alternative Names:
DZD8586
Birelentinib (DZD8586) is an orally effective, selective, non-covalent inhibitor targeting LYN tyrosine kinase and BTK tyrosine kinase, capable of penetrating the blood-brain barrier. Birelentinib exhibits concentration-dependent antiproliferative effects in RI-1 cells and diffuse large B-cell lymphoma (DLBCL) cell lines carrying BTK resistance mutations (such as C481X, V416L, etc.). Birelentinib blocks both BTK-dependent and independent signaling of the B-cell receptor (BCR), thereby inhibiting tumor cell proliferation and inducing cell death. Birelentinib can be used in research to overcome resistance to existing covalent and non-covalent BTK inhibitors in B-cell non-Hodgkin lymphoma (B-NHL)[1][2].
Molecular Weight:
453.44
CAS Number:
[2662512-15-2]
Formula:
C23H21F2N5O3
Target:
Btk,Src
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted